No Insurance? No Problem!
New Paths to Care for Relapsing Remitting MS
A significant percentage of people with Multiple Sclerosis (MS)—an estimated 10–20%—lose or lack insurance coverage each year due to policy changes and rising premiums. For these uninsured MS patients, access to vital medical care, disease-modifying therapies, and neurologist oversight is often severely limited, increasing risks of symptom progression and relapse.
Clinical research is becoming a crucial solution for uninsured MS patients. Participating in MS clinical trials offers access to advanced treatments, regular physician care, and often includes compensation for travel and medical costs, making it a practical care option for those without insurance.
Recent breakthroughs in MS research, such as the development of Frexalimab—a new monoclonal antibody targeting key immune pathways—are showing promise for improved outcomes and relapse reduction. By joining clinical trials, uninsured MS patients can access these innovative therapies while contributing to the advancement of MS treatment for the broader community.
As demand for accessible MS care grows, clinical research is bridging critical care gaps, offering hope and advanced options for those most affected by insurance loss.
Take the Next Step Toward Better MS Care
If you are living with Relapsing-Remitting Multiple Sclerosis (RRMS) and have lost insurance coverage, you don’t have to face these challenges alone. Clinical trials are now providing uninsured patients with access to advanced therapies, expert medical care, and the latest research—all at no cost. Many trials also offer travel and hotel accommodations to ensure you can attend appointments without added stress.
Take charge of your health today. Schedule a video or phone consultation with our medical advocacy team to discuss your options and get paired with a clinical trial site dedicated to supporting your care needs. Don’t miss this opportunity to receive comprehensive MS care and be part of the future of MS treatment.
Schedule a Video or Phone Consultation
